1. Home
  2. GOAI vs TENX Comparison

GOAI vs TENX Comparison

Compare GOAI & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eva Live Inc. Common Stock

GOAI

Eva Live Inc. Common Stock

BUY

Current Price

$1.55

Market Cap

62.0M

Sector

Technology

ML Signal

BUY

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

BUY

Current Price

$1.60

Market Cap

74.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GOAI
TENX
Founded
2015
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.0M
74.1M
IPO Year
2023
2001

Fundamental Metrics

Financial Performance
Metric
GOAI
TENX
Price
$1.55
$1.60
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $12.56
AVG Volume (30 Days)
111.5K
★ 2.1M
Earning Date
11-08-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 966.67
N/A
EPS
★ N/A
N/A
Revenue
★ $17,037,328.00
N/A
Revenue This Year
$14.45
N/A
Revenue Next Year
$53.85
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 82.59
N/A
52 Week Low
$1.42
$1.31
52 Week High
$6.67
$19.40

Technical Indicators

Market Signals
Indicator
GOAI
TENX
Relative Strength Index (RSI) 36.08 28.75
Support Level $1.42 $1.31
Resistance Level $2.66 $2.00
Average True Range (ATR) 0.17 0.11
MACD -0.02 0.07
Stochastic Oscillator 10.21 20.31

Price Performance

Historical Comparison
GOAI
TENX

About GOAI Eva Live Inc. Common Stock

Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: